Thanh Hue Dellinger

10PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 23, 2026
Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progress.

Vinita Popat, Paul H Frankel, Nora H Ruel

|Dec 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345.

Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu

|Apr 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate.

Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu

|Jan 08, 2025
Single-Cell Transcriptomics Sheds Light on Tumor Evolution: Perspectives from City of Hope's Clinical Trial Teams.

Patrick A Cosgrove, Andrea H Bild, Thanh H Dellinger

|Nov 30, 2023
Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian Cancer.

Ferdynand J Kos, Paul Frankel, Mihaela Cristea

|Jun 10, 2023
Complete Pathologic Response to PARP Inhibitor Olaparib in a Patient with Stage IVB Recurrent Endometrioid Endometrial Adenocarcinoma.

Rosemary Noel Senguttuvan, Christina Wei, Mustafa Raoof

Pageof 2

Frequent Collaborators

3 joint publications

Ernest S Han

3 joint publications

Rosemary Noel Senguttuvan

3 joint publications

Daniel Schmolze

3 joint publications

Hyejin Cho